
    
      Detailed Description:

      Additional Study Purpose Details: To assess the pharmacokinetics of metformin and PD 0332334
      with concurrent administration.

      On February 18th 2009, a decision to terminate further development for PD 0332334 was
      communicated to investigators in this study. The decision to terminate this study was not
      based on any safety concerns.
    
  